1850446
Last Update Posted: 2020-04-16
Recruiting has ended
All Genders accepted | 18 Years-70 Years |
184 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
The purpose of this study is:
- to assess the efficacy of Ergoferon in treatment of influenza;
- to assess the safety of Ergoferon in treatment of influenza;
- to compare the efficacy of Ergoferon and Oseltamivir for treatment of influenza.
The overall duration of a patient participation in the trial is 6 days (screening/randomization/therapy onset - day 1; study therapy period - day 1-5; follow-up period - day 6).
Eligibility
Relevant conditions:
Influenza
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov